Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery

NCT00082121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Ischemia
Coronary Arteriosclerosis
Aortic Valve Insufficiency
Mitral Valve Insufficiency

Interventions

DRUG: TP10

Sponsor

Avant Immunotherapeutics